The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)
Abstract
Autosomal dominant guanosine triphosphate cyclohydrolase I (GCH-I) deficiency (Segawa disease) is a dopa-responsive dystonia caused by mutation of the GCH-I gene located on 14q22.1-q22.2. Neurohistochemical examination revealed a decrease of the tyrosine hydroxylase protein as well as its activity in the striatum and decrease of dopamine content, particularly in its ventral portion rich in D1 receptors (striatal direct pathways). Neuroimaging, clinical neurophysiological, and biochemical studies showed preservation of the structure and function of the terminal of the nigrostriatal DA neuron. Clinical neurophysiological studies showed no progressive decrement of DA activities. As the enzymatic activity of pteridine metabolism is highest in the early developmental course, it may modulate dopamine receptors maturing early in the developmental course. Its product, tetrahydrobiopterin, has higher affinity to tyrosine hydroxylase among hydroxylases. Thus, partial deficiency of tetrahydrobiopterin caused by heterozygous mutation of the GCH-I gene decreases dopamine activity rather selectively. This affects the DA receptors that mature early and demonstrates characteristic symptoms age-dependently along with the developmental decrement of the tyrosine hydroxylase activities at the terminals and the maturational processes of the projecting neurons of the basal ganglia. A difference in the ratio of mutant/wild-type GCH-I mRNA that depends on the locus of mutation may explain intrafamilial and interfamilial variation of phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Neurobiology of Sleep: Genetics, cellular physiology and subcortical networks
Pace-Schott, E. F., & Hobson, J. A. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn895 · Cited by 937
Behavioral correlates of dopaminergic unit activity in freely moving cats
Steinfels, G. F., Heym, J., Strecker, R. E., & Jacobs, B. L. (1983) · Brain Research · doi:10.1016/0006-8993(83)91145-9 · Cited by 261
Cited by
The monoamine neurotransmitter disorders: an expanding range of neurological syndromes
Kurian, M. A., Gissen, P., Smith, M., Heales, S. J., & Clayton, P. T. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70141-7 · Cited by 351
Marras, C., Lang, A., van de Warrenburg, B. P., Sue, C. M., Tabrizi, S. J., Bertram, L., Mercimek‐Mahmutoglu, S., Ebrahimi‐Fakhari, D., Warner, T. T., Durr, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26527 · Cited by 285
Dopa-responsive dystonia—clinical and genetic heterogeneity
Wijemanne, S., & Jankovic, J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.86 · Cited by 263
Complex molecular regulation of tyrosine hydroxylase
Tekin, I., Roskoski, R., Carkaci-Salli, N., & Vrana, K. E. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1238-7 · Cited by 128
Dominant versus recessive: Molecular mechanisms in metabolic disease
Zschocke, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1016-5 · Cited by 33
Metadata
- Authors
- Segawa, M., Nomura, Y., & Nishiyama, N.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003
- Volume
- 54
- Issue
- S6
- Pages
- S32-S45
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1979708588
- Cited by
- 238
- References
- 2
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). https://app.cochat.ai/papers/10.1002/ana.10630
- The paper
- Segawa, M., Nomura, Y., & Nishiyama, N. (2003). Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Annals of Neurology. https://doi.org/10.1002/ana.10630
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.